Dicyclomine

Generic name: Pronounced as (dye sye' kloe meen)
Brand names
  • Bentyl®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 09/15/2017

Dicyclomine is used to treat the symptoms of irritable bowel syndrome. Dicyclomine is in a class of medications called anticholinergics. It relieves muscle spasms in the gastrointestinal tract by blocking the activity of a certain natural substance in the body.

Dicyclomine comes as a capsule, a tablet, and a syrup to take by mouth. It is usually taken 4 times a day. To help you remember to take dicyclomine, take it around the same times every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take dicyclomine exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Your doctor will probably start you on a low dose of dicyclomine and gradually increase your dose.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before taking dicyclomine,

  • tell your doctor and pharmacist if you are allergic to dicyclomine or any other medications.

  • tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking. Be sure to mention any of the following: amantadine (Symmetrel); antacids; antidepressants such as amitriptyline (Elavil), amoxapine (Asendin), clomipramine (Anafranil), desipramine (Norpramin), doxepin (Adapin, Sinequan), imipramine (Tofranil), nortriptyline (Aventyl, Pamelor), protriptyline (Vivactil), and trimipramine (Surmontil); antihistamines; diet pills; digoxin (Lanoxin); ipratropium (Atrovent); isosorbide (Imdur, Ismo, Isordil, others); medications for anxiety, asthma, glaucoma, irregular heartbeat, mental illness, motion sickness, Parkinson's disease, seizures, ulcers, or urinary problems; metoclopramide (Reglan); monoamine oxidase (MAO) inhibitors, including phenelzine (Nardil) and tranylcypromine (Parnate); narcotic pain relievers such as meperidine (Demerol); nitroglycerin (Nitro-Bid, Nitrostat, others); sedatives; sleeping pills; and tranquilizers. Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had glaucoma; ulcerative colitis (a condition which causes swelling and sores in the lining of the colon [large intestine] and rectum); an enlarged prostate (prostatic hyperplasia); difficulty urinating; esophageal reflux (heartburn); a blockage in the gastrointestinal tract; myasthenia gravis; high blood pressure; an overactive thyroid gland (hyperthyroidism); nerve disease (autonomic neuropathy); heart failure; rapid or pounding heartbeat; hiatal hernia; or liver, kidney, or heart disease.

  • tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking dicyclomine, call your doctor. Do not breast-feed while taking this medication.

  • talk to your doctor about the risks and benefits of taking dicyclomine if you are 65 years of age or older. Older adults should not usually take dicyclomine because it is not as safe or effective as other medications that can be used to treat the same condition.

  • if you are having surgery, including dental surgery, tell the doctor or dentist that you are taking dicyclomine.

  • you should know that dicyclomine may make you drowsy or cause blurred vision. Do not drive a car or operate machinery until you know how this medication affects you.

  • remember that alcohol can add to the drowsiness caused by this medication.

  • you should know that dicyclomine reduces the body's ability to cool off by sweating. In very high temperatures, dicyclomine can cause fever and heat stroke.

Unless your doctor tells you otherwise, continue your normal diet.

Take the missed dose as soon as you remember it. However, if it is almost time for the next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

  • Dicyclomine may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • dry mouth

    • upset stomach

    • vomiting

    • constipation

    • stomach pain

    • gas or bloating

    • loss of appetite

    • dizziness

    • tingling

    • headache

    • drowsiness

    • weakness

    • blurred vision

    • double vision

    • difficulty urinating

  • Some side effects can be serious. If you experience any of the following symptoms, call your doctor immediately:

    • hot, flushed, dry skin

    • confusion

    • forgetfulness

    • seeing things or hearing voices that do not exist (hallucinating)

    • unsteadiness

    • coma

    • anxiety

    • excessive tiredness

    • difficulty falling asleep or staying asleep

    • excitement

    • inappropriate mood

    • muscle weakness

    • rapid or pounding heartbeat

    • fainting

    • hives

    • skin rash

    • itching

    • difficulty breathing or swallowing

  • Dicyclomine may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

Keep this medication in the container it came in, tightly closed, and out of reach of children. Store it at room temperature and away from excess heat and moisture (not in the bathroom).

It is important to keep all medication out of sight and reach of children as many containers (such as weekly pill minders and those for eye drops, creams, patches, and inhalers) are not child-resistant and young children can open them easily. To protect young children from poisoning, always lock safety caps and immediately place the medication in a safe location – one that is up and away and out of their sight and reach. http://www.upandaway.org

Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. See the FDA's Safe Disposal of Medicines website (http://goo.gl/c4Rm4p) for more information if you do not have access to a take-back program.

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • headache

  • upset stomach

  • vomiting

  • blurred vision

  • dilated pupils

  • hot, dry skin

  • dizziness

  • dry mouth

  • difficulty swallowing

  • nervousness

  • excitement

  • seeing things or hearing voices that do not exist (hallucinating)

Keep all appointments with your doctor.

Do not let anyone else take your medication. Ask your pharmacist any questions you have about refilling your prescription.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Dolasetron Dolasetron Dolasetron may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Anagrelide Anagrelide The risk or severity of Tachycardia can be increased when Anagrelide is combined with Dicyclomine.
Bisacodyl Bisacodyl The therapeutic efficacy of Bisacodyl can be decreased when used in combination with Dicyclomine.
Cilostazol Cilostazol Dicyclomine may decrease the excretion rate of Cilostazol which could result in a higher serum level.
Diphenoxylate Diphenoxylate The risk or severity of adverse effects can be increased when Diphenoxylate is combined with Dicyclomine.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Fenofibrate Fenofibrate Dicyclomine may decrease the excretion rate of Fenofibrate which could result in a higher serum level.
Guanfacine Guanfacine Guanfacine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Magnesium Hydroxide Magnesium Hydroxide Dicyclomine may decrease the excretion rate of Magnesium hydroxide which could result in a higher serum level.
Magnesium Oxide Magnesium Oxide The therapeutic efficacy of Magnesium oxide can be decreased when used in combination with Dicyclomine.
Mycophenolate Mycophenolate Dicyclomine may decrease the excretion rate of Mycophenolic acid which could result in a higher serum level.
Naratriptan Naratriptan Naratriptan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Olsalazine Olsalazine Olsalazine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Paregoric Paregoric The risk or severity of adverse effects can be increased when Morphine is combined with Dicyclomine.
Pentazocine Pentazocine The risk or severity of adverse effects can be increased when Pentazocine is combined with Dicyclomine.
Polyethylene glycol-electrolyte solution (PEG-ES) Polyethylene glycol-electrolyte solution (PEG-ES) The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Dicyclomine.
Potassium Potassium Potassium may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Prednisone Prednisone Prednisone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Psyllium Psyllium The therapeutic efficacy of Plantago seed can be decreased when used in combination with Dicyclomine.
Ranitidine Ranitidine Dicyclomine may decrease the excretion rate of Ranitidine which could result in a higher serum level.
Reserpine Reserpine Reserpine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Rizatriptan Rizatriptan Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Rizatriptan.
Sumatriptan Sumatriptan Sumatriptan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Tacrolimus Tacrolimus Tacrolimus may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Tizanidine Tizanidine Tizanidine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Zolmitriptan Zolmitriptan Zolmitriptan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ampicillin Injection Ampicillin Injection Ampicillin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Doxycycline Injection Doxycycline Injection Doxycycline may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Fluconazole Injection Fluconazole Injection Fluconazole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Foscarnet Injection Foscarnet Injection Foscarnet may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hydromorphone Injection Hydromorphone Injection The risk or severity of adverse effects can be increased when Hydromorphone is combined with Dicyclomine.
Levofloxacin Injection Levofloxacin Injection Dicyclomine may decrease the excretion rate of Levofloxacin which could result in a higher serum level.
Meperidine Injection Meperidine Injection The risk or severity of adverse effects can be increased when Dicyclomine is combined with Meperidine.
Metoclopramide Injection Metoclopramide Injection The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Metoclopramide.
Morphine Injection Morphine Injection The risk or severity of adverse effects can be increased when Morphine is combined with Dicyclomine.
Pamidronate Injection Pamidronate Injection Pamidronic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Vancomycin Injection Vancomycin Injection Dicyclomine may decrease the excretion rate of Vancomycin which could result in a higher serum level.
Altretamine Altretamine Amphetamine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Cefuroxime Cefuroxime Cefuroxime may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cyclosporine Cyclosporine Cyclosporine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ondansetron Ondansetron Ondansetron may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Granisetron Granisetron Granisetron may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Torsemide Torsemide Torasemide may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Olanzapine Olanzapine Olanzapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Alosetron Alosetron Alosetron may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Entacapone Entacapone Entacapone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Meloxicam Meloxicam Meloxicam may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Oxcarbazepine Oxcarbazepine Oxcarbazepine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Pantoprazole Pantoprazole Pantoprazole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Temozolomide Temozolomide Dicyclomine may decrease the excretion rate of Temozolomide which could result in a higher serum level.
Zaleplon Zaleplon Zaleplon may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Desloratadine Desloratadine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Desloratadine.
Linezolid Linezolid Linezolid may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Rivastigmine Rivastigmine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Rivastigmine.
Trimipramine Trimipramine Trimipramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Glycopyrrolate Glycopyrrolate The risk or severity of adverse effects can be increased when Dicyclomine is combined with Glycopyrronium.
Perindopril Perindopril Perindopril may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Tenofovir Tenofovir Tenofovir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Choline Magnesium Trisalicylate Choline Magnesium Trisalicylate Choline magnesium trisalicylate may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Epinephrine Injection Epinephrine Injection The risk or severity of Tachycardia can be increased when Epinephrine is combined with Dicyclomine.
Eplerenone Eplerenone Eplerenone may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Escitalopram Escitalopram Escitalopram may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Zonisamide Zonisamide Zonisamide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Aripiprazole Aripiprazole Aripiprazole may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Atomoxetine Atomoxetine Atomoxetine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Dexmethylphenidate Dexmethylphenidate Dexmethylphenidate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Atazanavir Atazanavir Atazanavir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Almotriptan Almotriptan Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Almotriptan.
Eletriptan Eletriptan Eletriptan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Mefloquine Mefloquine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Mefloquine.
Polyethylene Glycol 3350 Polyethylene Glycol 3350 The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Dicyclomine.
Emtricitabine Emtricitabine Dicyclomine may decrease the excretion rate of Emtricitabine which could result in a higher serum level.
Memantine Memantine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Memantine.
Tegaserod Tegaserod The therapeutic efficacy of Tegaserod can be decreased when used in combination with Dicyclomine.
Tadalafil Tadalafil Dicyclomine may decrease the excretion rate of Tadalafil which could result in a higher serum level.
Frovatriptan Frovatriptan Frovatriptan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Apomorphine Injection Apomorphine Injection Apomorphine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Protriptyline Protriptyline Protriptyline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Duloxetine Duloxetine Duloxetine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Tinidazole Tinidazole Dicyclomine may decrease the excretion rate of Tinidazole which could result in a higher serum level.
Trospium Trospium The risk or severity of adverse effects can be increased when Trospium is combined with Dicyclomine.
Cefditoren Cefditoren Cefdinir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cyanocobalamin Injection Cyanocobalamin Injection Hydroxocobalamin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Eszopiclone Eszopiclone Eszopiclone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ganciclovir Ganciclovir Dicyclomine may decrease the excretion rate of Ganciclovir which could result in a higher serum level.
Ribavirin Ribavirin Dicyclomine may decrease the excretion rate of Ribavirin which could result in a higher serum level.
Solifenacin Solifenacin The risk or severity of adverse effects can be increased when Dicyclomine is combined with Solifenacin.
Valganciclovir Valganciclovir Dicyclomine may decrease the excretion rate of Valganciclovir which could result in a higher serum level.
Adefovir Adefovir Adefovir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Dextroamphetamine Dextroamphetamine Amphetamine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Pramlintide Injection Pramlintide Injection The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Dicyclomine.
Sodium Oxybate Sodium Oxybate Sodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Isocarboxazid Isocarboxazid Isocarboxazid may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ramelteon Ramelteon Ramelteon may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Darifenacin Darifenacin The risk or severity of adverse effects can be increased when Darifenacin is combined with Dicyclomine.
Fentanyl Fentanyl The risk or severity of adverse effects can be increased when Dicyclomine is combined with Fentanyl.
Pregabalin Pregabalin Pregabalin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Phenylephrine Phenylephrine The risk or severity of Tachycardia can be increased when Phenylephrine is combined with Dicyclomine.
Felbamate Felbamate Felbamate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ranolazine Ranolazine Ranolazine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Rasagiline Rasagiline Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Rasagiline.
Sitagliptin Sitagliptin Dicyclomine may decrease the excretion rate of Sitagliptin which could result in a higher serum level.
Varenicline Varenicline Dicyclomine may decrease the excretion rate of Varenicline which could result in a higher serum level.
Albuterol Albuterol Dicyclomine may decrease the excretion rate of Salbutamol which could result in a higher serum level.
Paliperidone Paliperidone Paliperidone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Clofarabine Injection Clofarabine Injection Clofarabine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Lubiprostone Lubiprostone Dicyclomine may decrease the excretion rate of Lubiprostone which could result in a higher serum level.
Pemetrexed Injection Pemetrexed Injection Dicyclomine may decrease the excretion rate of Pemetrexed which could result in a higher serum level.
Dimenhydrinate Dimenhydrinate Dimenhydrinate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Lisdexamfetamine Lisdexamfetamine The risk or severity of Tachycardia can be increased when Dicyclomine is combined with Lisdexamfetamine.
Nabilone Nabilone The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with Nabilone.
Sorafenib Sorafenib Sorafenib may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Dronabinol Dronabinol The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with Dronabinol.
Levocetirizine Levocetirizine Levocetirizine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Pegaptanib Injection Pegaptanib Injection Dicyclomine may decrease the excretion rate of Pegaptanib which could result in a higher serum level.
Azacitidine Injection Azacitidine Injection Dicyclomine may decrease the excretion rate of Azacitidine which could result in a higher serum level.
Paclitaxel (with polyoxyethylated castor oil) Injection Paclitaxel (with polyoxyethylated castor oil) Injection The therapeutic efficacy of Castor oil can be decreased when used in combination with Dicyclomine.
Lenalidomide Lenalidomide Lenalidomide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Budesonide Budesonide Dicyclomine may decrease the excretion rate of Budesonide which could result in a higher serum level.
Desmopressin Desmopressin Desmopressin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Betaine Betaine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Glycine betaine.
OnabotulinumtoxinA Injection OnabotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Dicyclomine is combined with Botulinum toxin type A.
RimabotulinumtoxinB Injection RimabotulinumtoxinB Injection The risk or severity of adverse effects can be increased when Dicyclomine is combined with Botulinum Toxin Type B.
Doripenem Injection Doripenem Injection Dicyclomine may decrease the excretion rate of Doripenem which could result in a higher serum level.
Arsenic Trioxide Injection Arsenic Trioxide Injection Dicyclomine may decrease the excretion rate of Arsenic trioxide which could result in a higher serum level.
Desvenlafaxine Desvenlafaxine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Desvenlafaxine.
Cevimeline Cevimeline Cevimeline may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Certolizumab Injection Certolizumab Injection Dicyclomine may decrease the excretion rate of Certolizumab pegol which could result in a higher serum level.
Daptomycin Injection Daptomycin Injection Daptomycin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Methylnaltrexone Injection Methylnaltrexone Injection Dicyclomine may decrease the excretion rate of Methylnaltrexone which could result in a higher serum level.
Rufinamide Rufinamide Rufinamide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Midazolam Midazolam Midazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Naltrexone Injection Naltrexone Injection The risk or severity of adverse effects can be increased when Dicyclomine is combined with Naltrexone.
Dexrazoxane Injection Dexrazoxane Injection Dexrazoxane may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Milnacipran Milnacipran Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Milnacipran.
Plerixafor Injection Plerixafor Injection Dicyclomine may decrease the excretion rate of Plerixafor which could result in a higher serum level.
Sodium Phosphate Sodium Phosphate The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Dicyclomine.
Fesoterodine Fesoterodine Dicyclomine may decrease the excretion rate of Fesoterodine which could result in a higher serum level.
Iloperidone Iloperidone Iloperidone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Prasugrel Prasugrel Dicyclomine may decrease the excretion rate of Prasugrel which could result in a higher serum level.
Lacosamide Lacosamide Lacosamide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) Tolvaptan may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
AbobotulinumtoxinA Injection AbobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Dicyclomine is combined with Botulinum toxin type A.
Pralatrexate Injection Pralatrexate Injection Dicyclomine may decrease the excretion rate of Pralatrexate which could result in a higher serum level.
Palonosetron Injection Palonosetron Injection Palonosetron may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Saxagliptin Saxagliptin Dicyclomine may decrease the excretion rate of Saxagliptin which could result in a higher serum level.
Telavancin Injection Telavancin Injection Dicyclomine may decrease the excretion rate of Telavancin which could result in a higher serum level.
Tapentadol Tapentadol The risk or severity of adverse effects can be increased when Tapentadol is combined with Dicyclomine.
Topotecan Topotecan Dicyclomine may decrease the excretion rate of Topotecan which could result in a higher serum level.
Asenapine Asenapine Asenapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Vigabatrin Vigabatrin Vigabatrin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Oxymorphone Oxymorphone The risk or severity of adverse effects can be increased when Oxymorphone is combined with Dicyclomine.
Dalfampridine Dalfampridine Dicyclomine may decrease the excretion rate of Dalfampridine which could result in a higher serum level.
IncobotulinumtoxinA Injection IncobotulinumtoxinA Injection The risk or severity of adverse effects can be increased when Dicyclomine is combined with Botulinum toxin type A.
Ceftaroline Injection Ceftaroline Injection Ceftaroline fosamil may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Lurasidone Lurasidone Lurasidone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Acetaminophen Injection Acetaminophen Injection Acetaminophen may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Vilazodone Vilazodone Vilazodone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ipilimumab Injection Ipilimumab Injection Dicyclomine may decrease the excretion rate of Ipilimumab which could result in a higher serum level.
Denileukin Diftitox Injection Denileukin Diftitox Injection Aldesleukin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Terbutaline Injection Terbutaline Injection The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Terbutaline.
Roflumilast Roflumilast Dicyclomine may decrease the excretion rate of Roflumilast which could result in a higher serum level.
Rivaroxaban Rivaroxaban Dicyclomine may decrease the excretion rate of Rivaroxaban which could result in a higher serum level.
Ruxolitinib Ruxolitinib Dicyclomine may decrease the excretion rate of Ruxolitinib which could result in a higher serum level.
Clobazam Clobazam Clobazam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Deferiprone Deferiprone Dicyclomine may decrease the excretion rate of Deferiprone which could result in a higher serum level.
Cabergoline Cabergoline Cabergoline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Naloxone Injection Naloxone Injection Dicyclomine may decrease the excretion rate of Naloxone which could result in a higher serum level.
Fondaparinux Injection Fondaparinux Injection Fondaparinux may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ezogabine Ezogabine Tiagabine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Enzalutamide Enzalutamide Dicyclomine may decrease the excretion rate of Enzalutamide which could result in a higher serum level.
Mirabegron Mirabegron The risk or severity of urinary retention can be increased when Dicyclomine is combined with Mirabegron.
Linaclotide Linaclotide The therapeutic efficacy of Linaclotide can be decreased when used in combination with Dicyclomine.
Teduglutide Injection Teduglutide Injection Dicyclomine may decrease the excretion rate of Teduglutide which could result in a higher serum level.
Alogliptin Alogliptin Dicyclomine may decrease the excretion rate of Alogliptin which could result in a higher serum level.
Pomalidomide Pomalidomide Pomalidomide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Canagliflozin Canagliflozin Dicyclomine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Methazolamide Methazolamide Methazolamide may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Trametinib Trametinib Dicyclomine may decrease the excretion rate of Trametinib which could result in a higher serum level.
Levomilnacipran Levomilnacipran Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Levomilnacipran.
Ertapenem Injection Ertapenem Injection Ertapenem may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Vortioxetine Vortioxetine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Vortioxetine.
Perampanel Perampanel Perampanel may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ketorolac Injection Ketorolac Injection Ketorolac may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Sofosbuvir Sofosbuvir Dicyclomine may decrease the excretion rate of Sofosbuvir which could result in a higher serum level.
Dapagliflozin Dapagliflozin Dapagliflozin may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Apremilast Apremilast Dicyclomine may decrease the excretion rate of Apremilast which could result in a higher serum level.
Droxidopa Droxidopa Dicyclomine may decrease the excretion rate of Droxidopa which could result in a higher serum level.
Eslicarbazepine Eslicarbazepine Eslicarbazepine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Testosterone Injection Testosterone Injection Testosterone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hydrocodone Hydrocodone The risk or severity of adverse effects can be increased when Hydrocodone is combined with Dicyclomine.
Suvorexant Suvorexant Suvorexant may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Edoxaban Edoxaban Dicyclomine may decrease the excretion rate of Edoxaban which could result in a higher serum level.
Methamphetamine Methamphetamine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Metamfetamine.
Tasimelteon Tasimelteon Tasimelteon may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Risperidone Injection Risperidone Injection Risperidone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Haloperidol Injection Haloperidol Injection Haloperidol may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Amiloride Amiloride Amiloride may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Macitentan Macitentan Dicyclomine may decrease the excretion rate of Macitentan which could result in a higher serum level.
Flibanserin Flibanserin Flibanserin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Brexpiprazole Brexpiprazole Brexpiprazole may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ziprasidone Injection Ziprasidone Injection Ziprasidone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Cariprazine Cariprazine Cariprazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Penicillin G Procaine Injection Penicillin G Procaine Injection Dicyclomine may decrease the excretion rate of Procaine benzylpenicillin which could result in a higher serum level.
Eluxadoline Eluxadoline The risk or severity of constipation can be increased when Dicyclomine is combined with Eluxadoline.
Ixazomib Ixazomib Dicyclomine may decrease the excretion rate of Ixazomib which could result in a higher serum level.
Lesinurad Lesinurad Dicyclomine may decrease the excretion rate of Lesinurad which could result in a higher serum level.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection Amphotericin B may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Brivaracetam Injection Brivaracetam Injection Brivaracetam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Midodrine Midodrine The risk or severity of Tachycardia can be increased when Midodrine is combined with Dicyclomine.
Pimavanserin Pimavanserin Pimavanserin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Diphenhydramine Injection Diphenhydramine Injection Diphenhydramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Furosemide Injection Furosemide Injection Furosemide may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Lixisenatide Injection Lixisenatide Injection Dicyclomine may decrease the excretion rate of Lixisenatide which could result in a higher serum level.
Doxepin (Insomnia) Doxepin (Insomnia) Doxepin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Plecanatide Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Dicyclomine.
Deutetrabenazine Deutetrabenazine Dicyclomine may decrease the excretion rate of Deutetrabenazine which could result in a higher serum level.
Valbenazine Valbenazine Dicyclomine may decrease the excretion rate of Valbenazine which could result in a higher serum level.
Safinamide Safinamide Safinamide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Naldemedine Naldemedine Dicyclomine may decrease the excretion rate of Naldemedine which could result in a higher serum level.
Benznidazole Benznidazole Dicyclomine may decrease the excretion rate of Benznidazole which could result in a higher serum level.
Delafloxacin Delafloxacin Dicyclomine may decrease the excretion rate of Delafloxacin which could result in a higher serum level.
Ertugliflozin Ertugliflozin Ertugliflozin may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Buprenorphine Injection Buprenorphine Injection The risk or severity of adverse effects can be increased when Buprenorphine is combined with Dicyclomine.
Apalutamide Apalutamide Dicyclomine may decrease the excretion rate of Apalutamide which could result in a higher serum level.
Baricitinib Baricitinib Dicyclomine may decrease the excretion rate of Baricitinib which could result in a higher serum level.
Lofexidine Lofexidine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Lofexidine.
Plazomicin Injection Plazomicin Injection Dicyclomine may decrease the excretion rate of Plazomicin which could result in a higher serum level.
Cannabidiol Cannabidiol The risk or severity of Tachycardia and drowsiness can be increased when Dicyclomine is combined with Cannabidiol.
Stiripentol Stiripentol Stiripentol may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Prucalopride Prucalopride Dicyclomine may decrease the excretion rate of Prucalopride which could result in a higher serum level.
Magnesium Citrate Magnesium Citrate The therapeutic efficacy of Magnesium citrate can be decreased when used in combination with Dicyclomine.
Acyclovir Ophthalmic Acyclovir Ophthalmic Acyclovir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Brexanolone Injection Brexanolone Injection Brexanolone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Solriamfetol Solriamfetol The risk or severity of Tachycardia can be increased when Solriamfetol is combined with Dicyclomine.
Pitolisant Pitolisant Dicyclomine may decrease the excretion rate of Pitolisant which could result in a higher serum level.
Phenytoin Injection Phenytoin Injection Phenytoin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Fosphenytoin Injection Fosphenytoin Injection Fosphenytoin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Lumateperone Lumateperone Lumateperone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Lasmiditan Lasmiditan Lasmiditan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Lemborexant Lemborexant Lemborexant may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Fenfluramine Fenfluramine Fenfluramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives Drospirenone may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Viloxazine Viloxazine Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Viloxazine.
Tobramycin Injection Tobramycin Injection Tobramycin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Fenoprofen Fenoprofen Fenoprofen may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Indomethacin Indomethacin Indomethacin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Mefenamic Acid Mefenamic Acid Mefenamic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Naproxen Naproxen Naproxen may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Tolmetin Tolmetin Tolmetin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Sulindac Sulindac Sulindac may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Trazodone Trazodone Trazodone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Isotretinoin Isotretinoin Dicyclomine may decrease the excretion rate of Isotretinoin which could result in a higher serum level.
Sucralfate Sucralfate Sucralfate may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Floxuridine Floxuridine Floxuridine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Metaxalone Metaxalone Metaxalone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Methotrexate Injection Methotrexate Injection Methotrexate may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Levorphanol Levorphanol The risk or severity of adverse effects can be increased when Levorphanol is combined with Dicyclomine.
Primidone Primidone Primidone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Methsuximide Methsuximide Methsuximide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Diethylpropion Diethylpropion Diethylpropion may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Chlorpromazine Chlorpromazine Chlorpromazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Diazepam Diazepam Diazepam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Oxazepam Oxazepam Oxazepam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Flurazepam Flurazepam Flurazepam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Clorazepate Clorazepate Clorazepic acid may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Lorazepam Lorazepam Lorazepam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Carmustine Carmustine Carmustine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Amantadine Amantadine Dicyclomine may decrease the excretion rate of Amantadine which could result in a higher serum level.
Codeine Codeine The risk or severity of adverse effects can be increased when Dicyclomine is combined with Codeine.
Meprobamate Meprobamate Meprobamate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Chlordiazepoxide Chlordiazepoxide Chlordiazepoxide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Bromocriptine Bromocriptine Bromocriptine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Metaproterenol Metaproterenol The risk or severity of Tachycardia can be increased when Dicyclomine is combined with Orciprenaline.
Tranylcypromine Tranylcypromine Tranylcypromine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Phenelzine Phenelzine Phenelzine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Procarbazine Procarbazine Procarbazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ergoloid Mesylates Ergoloid Mesylates Ergoloid mesylate may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Tetracycline Tetracycline Tetracycline may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Prochlorperazine Prochlorperazine Prochlorperazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Thioridazine Thioridazine Thioridazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Trifluoperazine Trifluoperazine Trifluoperazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Bleomycin Bleomycin Bleomycin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Sulfadiazine Sulfadiazine Sulfadiazine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Oxycodone Oxycodone The risk or severity of adverse effects can be increased when Oxycodone is combined with Dicyclomine.
Methadone Methadone The risk or severity of adverse effects can be increased when Methadone is combined with Dicyclomine.
Oxybutynin Oxybutynin The risk or severity of adverse effects can be increased when Dicyclomine is combined with Oxybutynin.
Benztropine Benztropine Benzatropine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Maprotiline Maprotiline Maprotiline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ibuprofen Ibuprofen Ibuprofen may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Trihexyphenidyl Trihexyphenidyl The risk or severity of adverse effects can be increased when Trihexyphenidyl is combined with Dicyclomine.
Orphenadrine Orphenadrine Orphenadrine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Perphenazine Perphenazine Perphenazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Azathioprine Azathioprine Dicyclomine may decrease the excretion rate of Azathioprine which could result in a higher serum level.
Fluphenazine Fluphenazine Fluphenazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Phentermine Phentermine The risk or severity of Tachycardia can be increased when Phentermine is combined with Dicyclomine.
Methylphenidate Methylphenidate Methylphenidate may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Amoxapine Amoxapine Amoxapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Sulfasalazine Sulfasalazine Sulfasalazine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Mechlorethamine Mechlorethamine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Mechlorethamine.
Pyridostigmine Pyridostigmine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Pyridostigmine.
Phenazopyridine Phenazopyridine Phenazopyridine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Carbamazepine Carbamazepine Dicyclomine may decrease the excretion rate of Carbamazepine which could result in a higher serum level.
Molindone Molindone Molindone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Methyldopa Methyldopa Dicyclomine may decrease the excretion rate of Methyldopa which could result in a higher serum level.
Clonidine Clonidine Clonidine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hydralazine Hydralazine Dicyclomine may decrease the excretion rate of Hydralazine which could result in a higher serum level.
Cimetidine Cimetidine Cimetidine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Gentamicin Injection Gentamicin Injection Gentamicin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Warfarin Warfarin Dicyclomine may decrease the excretion rate of Warfarin which could result in a higher serum level.
Clonazepam Clonazepam Clonazepam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Promethazine Promethazine Promethazine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Meclofenamate Meclofenamate Meclofenamic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Nitrofurantoin Nitrofurantoin Nitrofurantoin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Digoxin Digoxin Dicyclomine may decrease the excretion rate of Digoxin which could result in a higher serum level.
Loxapine Loxapine Loxapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Chloroquine Chloroquine Chloroquine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Quinine Quinine Quinine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ethosuximide Ethosuximide Ethosuximide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Triamterene Triamterene Triamterene may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Lactulose Lactulose The therapeutic efficacy of Lactulose can be decreased when used in combination with Dicyclomine.
Chlorothiazide Chlorothiazide Dicyclomine may increase the excretion rate of Chlorothiazide which could result in a lower serum level and potentially a reduction in efficacy.
Chlorthalidone Chlorthalidone Dicyclomine may increase the excretion rate of Chlorthalidone which could result in a lower serum level and potentially a reduction in efficacy.
Metolazone Metolazone Metolazone may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Isosorbide Isosorbide Isosorbide may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Secobarbital Secobarbital Secobarbital may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Desipramine Desipramine Desipramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Amitriptyline Amitriptyline Amitriptyline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Imipramine Imipramine Imipramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Probenecid Probenecid Dicyclomine may decrease the excretion rate of Probenecid which could result in a higher serum level.
Quinidine Quinidine Dicyclomine may decrease the excretion rate of Quinidine which could result in a higher serum level.
Procainamide Procainamide Procainamide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Isoniazid Isoniazid Dicyclomine may decrease the excretion rate of Isoniazid which could result in a higher serum level.
Pyrazinamide Pyrazinamide Pyrazinamide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Disopyramide Disopyramide Disopyramide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Valproic Acid Valproic Acid Valproic acid may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Butabarbital Butabarbital Butabarbital may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Liothyronine Liothyronine Liothyronine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Methimazole Methimazole Methimazole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Chlorpropamide Chlorpropamide Chlorpropamide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Glucagon Injection Glucagon Injection Dicyclomine may increase the gastrointestinal motility reducing activities of Glucagon.
Tolbutamide Tolbutamide Dicyclomine may decrease the excretion rate of Tolbutamide which could result in a higher serum level.
Tolazamide Tolazamide Dicyclomine may decrease the excretion rate of Tolazamide which could result in a higher serum level.
Dextromethorphan Dextromethorphan Dextromethorphan may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Cyclobenzaprine Cyclobenzaprine Cyclobenzaprine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Baclofen Baclofen Baclofen may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Doxylamine Doxylamine Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Cyproheptadine Cyproheptadine Cyproheptadine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Clemastine Clemastine Clemastine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Chlorpheniramine Chlorpheniramine Chlorpheniramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Brompheniramine Brompheniramine Dexbrompheniramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Meclizine Meclizine Meclizine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ethambutol Ethambutol Ethambutol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Methyclothiazide Methyclothiazide Dicyclomine may increase the excretion rate of Methyclothiazide which could result in a lower serum level and potentially a reduction in efficacy.
Hydrochlorothiazide Hydrochlorothiazide Hydrochlorothiazide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Dantrolene Dantrolene Dantrolene may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Chlorzoxazone Chlorzoxazone Chlorzoxazone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Carisoprodol Carisoprodol Carisoprodol may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Methocarbamol Methocarbamol Methocarbamol may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Pyridoxine Pyridoxine Pyridoxine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Folic Acid Folic Acid Folic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Propranolol (Cardiovascular) Propranolol (Cardiovascular) Propranolol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Pseudoephedrine Pseudoephedrine The risk or severity of Tachycardia can be increased when Dicyclomine is combined with Pseudoephedrine.
Nortriptyline Nortriptyline Nortriptyline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Spironolactone Spironolactone Spironolactone may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy.
Amphotericin B Injection Amphotericin B Injection Amphotericin B may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Phytonadione Phytonadione Dicyclomine may decrease the excretion rate of Phylloquinone which could result in a higher serum level.
Amikacin Injection Amikacin Injection Amikacin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Nadolol Nadolol Dicyclomine may decrease the excretion rate of Nadolol which could result in a higher serum level.
Butorphanol Injection Butorphanol Injection The risk or severity of adverse effects can be increased when Butorphanol is combined with Dicyclomine.
Nalbuphine Injection Nalbuphine Injection The risk or severity of adverse effects can be increased when Nalbuphine is combined with Dicyclomine.
Allopurinol Allopurinol Allopurinol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Trimethobenzamide Trimethobenzamide Trimethobenzamide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Flavoxate Flavoxate Dicyclomine may decrease the excretion rate of Flavoxate which could result in a higher serum level.
Colchicine Colchicine Dicyclomine may decrease the excretion rate of Colchicine which could result in a higher serum level.
Cefaclor Cefaclor Cefaclor may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cefadroxil Cefadroxil Cefadroxil may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cefazolin Injection Cefazolin Injection Cefazolin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cephalexin Cephalexin Cephalexin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cefoxitin Injection Cefoxitin Injection Cefoxitin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Dacarbazine Dacarbazine Dicyclomine may decrease the excretion rate of Dacarbazine which could result in a higher serum level.
Acetazolamide Acetazolamide Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Cefotaxime Injection Cefotaxime Injection Cefotaxime may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Calcitonin Salmon Injection Calcitonin Salmon Injection Salmon calcitonin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Pyrantel Pyrantel Pyrantel may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Thiotepa Injection Thiotepa Injection The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Thiotepa.
Isoxsuprine Isoxsuprine The risk or severity of Tachycardia can be increased when Dicyclomine is combined with Isoxsuprine.
Ethacrynic Acid Ethacrynic Acid Etacrynic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Colistimethate Injection Colistimethate Injection Colistimethate may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Metoprolol Metoprolol Metoprolol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Hydroxyzine Hydroxyzine Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Thiothixene Thiothixene Thiothixene may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Aspirin Aspirin Acetylsalicylic acid may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Salsalate Salsalate Salsalate may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Alprazolam Alprazolam Alprazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Temazepam Temazepam Temazepam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Triazolam Triazolam Triazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Hyoscyamine Hyoscyamine The risk or severity of adverse effects can be increased when Hyoscyamine is combined with Dicyclomine.
Propantheline Propantheline Propantheline may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Trimethoprim Trimethoprim Trimethoprim may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Nifedipine Nifedipine Dicyclomine may decrease the excretion rate of Nifedipine which could result in a higher serum level.
Timolol Timolol Timolol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Verapamil Verapamil Verapamil may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Pindolol Pindolol Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Pindolol.
Cisplatin Injection Cisplatin Injection Cisplatin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Diflunisal Diflunisal Diflunisal may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Piroxicam Piroxicam Piroxicam may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Bumetanide Bumetanide Dicyclomine may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy.
Glipizide Glipizide Dicyclomine may decrease the excretion rate of Glipizide which could result in a higher serum level.
Indapamide Indapamide Dicyclomine may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy.
Amoxicillin Amoxicillin Dicyclomine may decrease the excretion rate of Amoxicillin which could result in a higher serum level.
Oxacillin Injection Oxacillin Injection Oxacillin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Pentoxifylline Pentoxifylline Dicyclomine may decrease the excretion rate of Pentoxifylline which could result in a higher serum level.
Pentamidine Injection Pentamidine Injection Pentamidine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ceftriaxone Injection Ceftriaxone Injection Ceftriaxone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Labetalol Labetalol Labetalol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Auranofin Auranofin Dicyclomine may decrease the excretion rate of Auranofin which could result in a higher serum level.
Leuprolide Injection Leuprolide Injection Leuprolide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Gemfibrozil Gemfibrozil Dicyclomine may decrease the excretion rate of Gemfibrozil which could result in a higher serum level.
Guanabenz Guanabenz The risk or severity of Tachycardia can be increased when Guanabenz is combined with Dicyclomine.
Dipivefrin Ophthalmic Dipivefrin Ophthalmic Adefovir dipivoxil may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ceftazidime Injection Ceftazidime Injection Ceftazidime may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ketoprofen Ketoprofen Ketoprofen may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cefotetan Injection Cefotetan Injection Cefotetan may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Pimozide Pimozide Pimozide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Flurbiprofen Flurbiprofen Flurbiprofen may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Aztreonam Injection Aztreonam Injection Aztreonam may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Buspirone Buspirone Buspirone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ciprofloxacin Ciprofloxacin Ciprofloxacin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Mesalamine Mesalamine Mesalazine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Diclofenac Diclofenac Diclofenac may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Fluoxetine Fluoxetine Fluoxetine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Clozapine Clozapine Clozapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Estazolam Estazolam Estazolam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Didanosine Didanosine Dicyclomine may decrease the excretion rate of Didanosine which could result in a higher serum level.
Pentostatin Injection Pentostatin Injection Pentostatin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Etodolac Etodolac Etodolac may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Fosinopril Fosinopril Fosinopril may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Nabumetone Nabumetone Nabumetone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Lisinopril Lisinopril Lisinopril may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Oxaprozin Oxaprozin Oxaprozin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Bisoprolol Bisoprolol Bisoprolol may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Zolpidem Zolpidem Zolpidem may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Isradipine Isradipine Isradipine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cisapride Cisapride Cisapride may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Gabapentin Gabapentin Gabapentin may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Venlafaxine Venlafaxine Venlafaxine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Nizatidine Nizatidine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Nizatidine.
Fluvoxamine Fluvoxamine Fluvoxamine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Nefazodone Nefazodone Dicyclomine may increase the central nervous system depressant (CNS depressant) activities of Nefazodone.
Lamotrigine Lamotrigine Lamotrigine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Valacyclovir Valacyclovir Valaciclovir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Tramadol Tramadol The risk or severity of adverse effects can be increased when Tramadol is combined with Dicyclomine.
Carboplatin Injection Carboplatin Injection Carboplatin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ifosfamide Injection Ifosfamide Injection Dicyclomine may decrease the excretion rate of Ifosfamide which could result in a higher serum level.
Nicardipine Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is combined with Dicyclomine.
Bupropion Bupropion Bupropion may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Ticlopidine Ticlopidine Ticlopidine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Metformin Metformin Metformin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Nisoldipine Nisoldipine Nisoldipine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Lamivudine Lamivudine Lamivudine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Riluzole Riluzole Riluzole may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Acarbose Acarbose Acarbose may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Gemcitabine Injection Gemcitabine Injection Gemcitabine may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cidofovir Injection Cidofovir Injection Cidofovir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Meropenem Injection Meropenem Injection Meropenem may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Clomipramine Clomipramine Clomipramine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Fosfomycin Fosfomycin Dicyclomine may decrease the excretion rate of Fosfomycin which could result in a higher serum level.
Mirtazapine Mirtazapine Mirtazapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Topiramate Topiramate The risk or severity of hyperthermia and oligohydrosis can be increased when Dicyclomine is combined with Topiramate.
Pramipexole Pramipexole Pramipexole may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Donepezil Donepezil The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Donepezil.
Loratadine Loratadine Dicyclomine may increase the anticholinergic activities of Loratadine.
Nilutamide Nilutamide Nilutamide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Flutamide Flutamide Flutamide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Selegiline Selegiline Selegiline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Sertraline Sertraline Sertraline may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Tamsulosin Tamsulosin Tamsulosin may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Ropinirole Ropinirole Ropinirole may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Quetiapine Quetiapine Quetiapine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Cefepime Injection Cefepime Injection Cefepime may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cefprozil Cefprozil Cefprozil may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cefpodoxime Cefpodoxime Cefpodoxime may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Cetirizine Cetirizine Cetirizine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Paroxetine Paroxetine Paroxetine may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Tolcapone Tolcapone Tolcapone may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Citalopram Citalopram Citalopram may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Capecitabine Capecitabine Dicyclomine may decrease the excretion rate of Capecitabine which could result in a higher serum level.
Efavirenz Efavirenz Efavirenz may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Abacavir Abacavir Dicyclomine may decrease the excretion rate of Abacavir which could result in a higher serum level.
Celecoxib Celecoxib Celecoxib may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Rosiglitazone Rosiglitazone Rosiglitazone may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Tolterodine Tolterodine Dicyclomine may decrease the excretion rate of Tolterodine which could result in a higher serum level.
Thalidomide Thalidomide Thalidomide may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Oseltamivir Oseltamivir Oseltamivir may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Balsalazide Balsalazide Balsalazide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Nateglinide Nateglinide Nateglinide may decrease the excretion rate of Dicyclomine which could result in a higher serum level.
Galantamine Galantamine The therapeutic efficacy of Dicyclomine can be decreased when used in combination with Galantamine.
Levetiracetam Levetiracetam Levetiracetam may increase the central nervous system depressant (CNS depressant) activities of Dicyclomine.
Rabeprazole Rabeprazole Dicyclomine may decrease the excretion rate of Rabeprazole which could result in a higher serum level.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists